You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 871 Combining KRASG12C(ON) inhibitor with SHP2 and/or immune checkpoint blockade to overcome adaptive resistance and enhance anti-tumour immunity in lung cancer

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
871 Combining KRASG12C(ON) inhibitor with SHP2 and/or immune checkpoint blockade to overcome adaptive resistance and enhance anti-tumour immunity in lung cancer

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023118012
Dec 202336010
Jan 20242903
Feb 20245004
Mar 20246007
Apr 20243604
May 20247202
Jun 20241601
Jul 20241004
Aug 20243008
Sep 20242402
Oct 20243204
Nov 20241605
Dec 20241207
Jan 20253406
Feb 2025003
Mar 2025009
Apr 2025005
May 2025006
Jun 2025004
Total5750106